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Abstract
Background: Lean mass is positively associated with bone mineral density (BMD).
However, the relationship between adiposity and BMD is more controversial. In particu-
lar, it is unclear if the observational association between the two reflects a causal effect
of fat mass on BMD. Previous Mendelian randomization (MR) studies using variants in
the FTO and MC4R genes as genetic instruments for adiposity have suggested that fat
mass does indeed causally influence BMD. However, it is possible that these genetic vari-
ants pleiotropically influence lean mass and affect BMD through pathways independent
of adiposity, invalidating one of the core assumptions of MR and complicating interpret-
ation of the analysis.
Methods: To investigate whether adiposity causally affects BMD, we investigated the re-
lationship between fat mass and BMD at the skull (SK), upper limbs (UL) and lower limbs
(LL), spine (SP) and pelvis (PE), using 32 body mass index (BMI)-associated SNPs, includ-
ing a variant near ADCY3 that was strongly associated with fat but not lean mass in our
sample. Dual-energy X-ray absorptiometry (DXA) scans and genetic data were available
for 5221 subjects (mean age 9.9 years) from the Avon Longitudinal Study of Parents and
Children. We performed a series of MR analyses involving single BMI-associated SNPs
and allelic scores of these SNPs. We used new extensions of the MR method including
MR Egger regression and multivariable MR, which are more robust to possible
confounding effects due to horizontal pleiotropy and, in the case of multivariable MR,
specifically account for the effect of lean mass in the analysis. Bidirectional Mendelian
randomization analysis was also performed to examine whether BMD causally affected
BMI and adiposity.
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Results: Observationally, fat mass was strongly positively related to BMD at all sites, but
more weakly at the skull. Instrumental variables (IV) analyses using an allelic score of
BMI SNPs suggested that fat mass was causally related to LL-BMD, UL-BMD, SP-BMD
and PE-BMD but not SK-BMD. Multivariable MR, Egger regression and IV analyses
involving the ADCY3 variant suggested a positive causal effect of adiposity on all sites
except the skull, and that an effect was present even after taking lean mass into account.
Finally, IV analyses using BMD allelic scores showed no evidence of reverse causality be-
tween BMD and fat mass.
Conclusions: Our results suggest that adiposity is causally related to increased BMD at
all sites except the skull, perhaps reflecting positive effects of loading on bone formation
at weighted but not unweighted sites. In contrast, we found no evidence for BMD caus-
ally affecting BMI or measures of adiposity. Our results illustrate how MR can be used
profitably to investigate clinical questions relevant to osteoporosis.
Key words: Bone, body mass index, genetics, Mendelian randomization, ALSPAC
Introduction
Mendelian randomization (MR) is an epidemiological
method that uses genetic variants robustly associated with
a modifiable exposure or biological intermediate of interest
to estimate the causal relationship between these variables
and a medically relevant outcome.1 The basic principle uti-
lized in MR is that if genetic variants either alter the level
of or mirror the biological effects of (i.e. through linkage
disequilibrium) a modifiable exposure that itself alters dis-
ease risk, then these genetic variants should be related to
disease risk to the extent predicted by their influence on ex-
posure to the risk factor. Mendel’s Law of Segregation
guarantees that genetic variants are transmitted randomly
and independently of potentially confounding environmen-
tal factors, and Mendel’s Law of Independent Assortment
implies that genetic variants should also segregate inde-
pendently of other traits provided certain assumptions are
met. This randomization achieved through the process of
segregation and assortment means that MR studies share
many similarities with randomized controlled trials and
are often robust to the issues of confounding and reverse
causality which plague traditional observational
epidemiological studies. The assumptions underlying the
MR approach as well as its limitations have been discussed
in detail elsewhere1–4 (see also Figure 1).
Previously, Timpson et al. (2009)5 used the Mendelian
randomization paradigm to examine a possible causal rela-
tionship between adiposity and bone mass using body
mass index (BMI)-associated variants in the FTO and
MC4R genes.6,7 The authors found strong association be-
tween variants in FTO and MC4R and BMD, interpreted
as a positive causal effect of adiposity on BMD. However,
BMI reflects lean as well as fat mass, and it has subse-
quently become clear that FTO and MC4R are likewise
associated with both fat and lean mass, possibly reflecting
relationships with overall body size. Hence pleiotropic ef-
fects on lean body mass may have contributed to observed
associations between FTO and MC4R and BMD.
In order to ascertain whether the results of these MR
analyses reflect a true causal effect of adiposity on BMD
(as opposed to a causal effect of lean mass on BMD
induced through the pleiotropic actions of the FTO and
MC4R variants), we examined the relationship between
adiposity and BMD at the skull (SK), upper limbs (UL),
KEY MESSAGES
• Mendelian randomization approaches suggest that adiposity is causally related to increased bone mineral density of
the limbs, pelvis and spine, but not the skull.
• This relationship may reflect positive effects of loading on bone formation at weighted but not unweighted sites.
• No evidence of reverse causality was detected, suggesting that bone mineral density is not causally related to
adiposity.
• Mendelian randomization can be used profitably to investigate clinical questions relevant to osteoporosis and bone
health.
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spine (SP), pelvis (PE) and lower limbs (LL) using 32 BMI-
associated SNPs, including a variant near ADCY3 that was
strongly associated with fat mass but not lean mass in our
sample. We argue that if adiposity causally increases
BMD, we would expect to see a relationship between
BMD and SNPs related to fat mass only. Furthermore, if
this causal relationship is mediated by loading (i.e. rather
than, say, through an endocrine effect), the causal effect es-
timate should be strongest at the lower limbs and weakest
at the skull.
We also utilized two relatively new extensions of the
MR method—multivariable MR8 and MR Egger regres-
sion9 which are more robust to violations of the exclusion
restriction criterion (i.e. the assumption of no horizontal
pleiotropy) than standard MR—to provide further evi-
dence in support of a causal effect of adiposity on BMD.
Briefly, multivariable MR uses multiple genetic variants
associated with several measured risk factors to simultan-
eously estimate the causal effect of each of the risk factors
on the outcome.8,10 Intuitively, multivariable MR can be
thought of as a two-stage procedure where multiple expos-
ures are first regressed on several genetic instruments in a
multivariate regression. In the second stage, the outcome
of interest is then regressed on the predicted values from
the first-stage regression using multivariable regression,
analogous to the two-stage least squares procedure utilized
in single variable MR. Multivariable MR makes the critical
assumption that the relationship between the genetic in-
struments and the outcome is mediated exclusively by the
exposure variables considered in the analysis, which of
course may not be the case in reality. In the present study,
we used multivariable MR analysis to estimate the causal
effect of lean and fat mass on BMD. Provided the above as-
sumptions are satisfied, the results of this analysis should
yield estimates of the (direct) causal effect of fat mass on
BMD, even if the genetic variants used in this study also
pleiotropically affect lean mass.8
A new statistical procedure called MR Egger regression
was additionally used to exclude the possibility that the re-
sults of our MR analyses were contaminated due to viola-
tions of the restriction exclusion assumption through
horizontal pleiotropy (i.e. adiposity associated variants
also directly influence lean mass which then influences
BMD). MR Egger regression is more flexible than multi-
variable MR in that there is no requirement to measure po-
tential pleiotropic pathways directly. Rather, the
procedure involves regressing estimates of the instrument-
outcome association on estimates of the instrument-expos-
ure association. Provided certain assumptions are met, the
slope of the weighted regression line provides an estimate
of the causal effect of the exposure on the outcome free
from the effects of horizontal pleiotropy. The intercept in
the regression is a function of extent of directional plei-
otropy in the data aggregated across all the different vari-
ants used in the analysis, and statistical tests of the degree
to which the intercept differs from zero are akin to testing
for the overall presence of directional pleiotropy in the
data. However, the validity of MR Egger regression rests
on the ‘INSIDE assumption’ (INstrument Strength is
Independent of Direct Effect) which states that across all
instruments there should be no correlation between the
strength with which the instrument proxies the exposure of
Figure 1 Directed acyclic graph illustrating core instrumental variable assumptions of the Mendelian randomisation approach. The SNP/allelic score
used as an instrumental variable (Z) is (1) associated with the exposure of interest (X), (2) independent of unmeasured confounders (U), and (3) inde-
pendent of the outcome (Y) given the exposure and unmeasured confounding factors. Estimates of the causal effect of the exposure on the outcome
can be obtained using a number of estimators including the ratio of the estimated instrumental variable and outcome association to the instrumental
variable and exposure association.
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interest, and its degree of association with the outcome via
pathways other than through the exposure. This is a
weaker requirement than the exclusion restriction criterion
in normal MR which postulates that SNPs may only influ-
ence the outcome through the exposure of interest, and so
MR Egger regression is likely to be more robust to horizon-
tal pleiotropy than standard MR approaches, although this
appears to come at the cost of decreased power to detect a
causal effect.9 In the context of the present study, provided
the underlying assumptions are met, the slope of the MR
Egger regression analysis should yield an estimate of the
causal effect of adiposity on BMD that is free from any
confounding effects due to horizontal pleiotropy (i.e. re-
gardless of whether horizontal pleiotropy is mediated
through lean mass or not).
Finally, we investigated whether our sample showed
any evidence for reverse causality (i.e. BMD causally influ-
encing BMI/adiposity) by performing bidirectional
MR11,12 in which we examined the relationship between
SNPs that proxy BMD, and through BMD their possible
effect on BMI/adiposity.
Methods
Subjects
ALSPAC is a geographically based UK cohort that recruited
pregnant women residing in Avon (South West England)
with an expected date of delivery between 1 April 1991 and
31 December 1992. A total of 15 247 pregnancies were en-
rolled, with 14 775 children born.13,14 Of these births,
14 701 children were alive at 12 months. The present study
is based on research clinics to which the whole cohort was
invited, held when participants were aged a mean of 9.9
years. Ethical approval was obtained from the ALSPAC
Law and Ethics committee, and the local research ethics
committees. Parental consent and child’s assent were ob-
tained for all measurements made. Please note that the study
website contains details of all the data that are available
through a fully searchable data dictionary [http://www.bris.
ac.uk/alspac/researchers/data-access/data-dictionary/].
Total-body dual-energy X-ray absorptiometry and
anthropometric measures
Total-body dual-energy X-ray absorptiometry (TB-DXA)
scans were performed on all participants at the age 9.9 years
clinic, using a Lunar Prodigy scanner (Lunar Radiation
Corp, Madison, WI) with paediatric scanning software (GE
Healthcare Bio-Sciences Corp., Piscataway, NJ). Dual-en-
ergy X-ray absorptiometry (DXA) measures of BMD were
derived for the following regions of interest: total body less
head (TBLH), skull (SK), upper limb (UL), lower limb (LL),
spine (SP) and pelvis (PE). All DXA scans were subsequently
reviewed by a trained researcher and re-analysed as neces-
sary, to ensure that borders between adjacent regions of
interest (ROIs) were placed correctly by the automated soft-
ware. The coefficient of variation for TBLH-BMD measures
was 0.8%, based on the analysis of 122 children who had
two scans performed on the same day. Data on lean mass
and fat mass were also obtained from the above-mentioned
scans. Height was measured to the nearest 0.1 cm using a
Harpenden stadiometer (Holtain Ltd, Crymych, UK) and
weight was measured to the nearest 50 g using Tanita
weighing scales (Tanita UK Ltd, Uxbridge). BMI was
derived as a ratio of body mass (kg) to height squared (m2).
Genetic data
A total of 9912 subjects were genotyped using the Illumina
HumanHap550 quad genome-wide SNP genotyping plat-
form (Illumina Inc., San Diego, CA, USA) by Logistics and
Genotyping Facilities at the Wellcome Trust Sanger Institute
and Laboratory Corporation of America (LabCorp
Holdings, Burlington, NC, USA) using support from 23 and
Me. PLINK software (v1.07) was used to carry out quality
control measures.15 Individuals were excluded from further
analysis on the basis of having incorrect gender assignments,
minimal or excessive heterozygosity (< 0.320 and > 0.345
for the Sanger data and < 0.310 and > 0.330 for the
LabCorp data), disproportionate levels of individual miss-
ingness (> 3%), evidence of cryptic relatedness (> 10%
Identity by descent (IBD)) and being of non-European ances-
try (as detected by a multidimensional scaling analysis
seeded with HapMap 2 individuals). EIGENSTRAT ana-
lysis16 revealed no additional obvious population stratifica-
tion and genome-wide analyses with other phenotypes in the
same cohort indicate a low lambda. SNPs with a minor allele
frequency of < 1% and call rate of < 95% were removed.
Furthermore, only SNPs that passed an exact test of Hardy–
Weinberg equilibrium (P > 5 107) were considered for
analysis. After quality control, 8365 unrelated individuals
who were genotyped at 500 527 SNPs were available for
analysis. Known autosomal variants were imputed with
Markov Chain Haplotyping software (MACH 1.0.16)17,18
using Centre d’Etude du Polymorphisme Humain (CEPH)
individuals from phase II of the HapMap project (hg18) as a
reference set (release 22).19
Cross-sectional analyses
All statistical analyses were performed using datasets re-
stricted to children with complete data across all genotypic
and phenotypic variables (5221 participants).
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Observational associations between BMD across five body
sites (SK, UL, SP, PE and LL) and BMI, total body fat mass
and total body lean mass were estimated using ordinary
least squares linear regression while controlling for age and
sex.
SNPs robustly related to BMI on the basis of a previous
genome-wide association study,20 as well as those related
to BMD21 were extracted from the complete set of
ALSPAC genome-wide imputed genotypes in order to
proxy BMI, hip-BMD and spine-BMD (see Supplementary
Tables 1, 2 and 3 for a list of SNPs used to proxy each
trait, available as Supplementary data at IJE online). Since
the majority of SNPs only explained small amounts of vari-
ance in our variables, we also constructed allelic scores of
SNPs in order to better proxy our exposures of interest.
Unweighted allelic scores were calculated as a simple count
of the number of trait increasing alleles. For bidirectional
IV analyses, two allele scores were generated—one consist-
ing of SNPs associated with bone mineral density at the
femoral neck of the hip (FN-BMD) and one consisting of
SNPs associated with bone mineral density at the lumbar
spine (LS-BMD) using genome-wide significant SNPs from
a study by Estrada and colleagues21—see Supplementary
Tables 2 and 3.
Instrumental variables regression
In order to generate estimates of the causal effect of BMI/
adiposity on BMD at the various body sites, instrumental
variables analyses were performed using two-stage least
squares. Analyses were performed both for single variants
and for allelic scores. Within these models, sex and age
were included as covariates in order to generate estimates
from the IV analyses that were comparable to those from
the observational regressions. IV estimates were then con-
trasted to those from ordinary linear regression using the
Durbin form of the Durbin-Wu-Hausman statistic. We
also examined instrument strength by deriving F-statistics
from the first stage regressions (i.e. Ffirst). As a rule of
thumb, F-statistics greater than 10 are often taken to indi-
cate adequate strength to mitigate against any bias of the
causal IV estimate.22 To investigate the possibility of re-
verse causation, we performed bidirectional MR12 to
examine the causal effect of BMD (measured at the skull,
spine, pelvis, upper and lower limbs) on BMI and total
body fat mass. For these analyses, BMI and fat mass were
log transformed to normality. Standard MR analyses as-
sume that genetic instruments only influence the outcome
(i.e. BMD) through the exposure of interest (i.e. fat mass).
However, BMI-associated SNPs may influence BMD
through pathways other than adiposity, including through
effects on lean mass. We therefore tested the robustness of
our results by utilizing two relatively new extensions of the
MR method, multivariable MR8,10 and MR Egger regres-
sion9 which, provided certain assumptions are met, help to
control for biases brought about through horizontal
pleiotropy.
Multivariable Mendelian randomization
We used multivariable MR to estimate the causal effect of
fat mass and lean mass on BMD using a two-stage least
squares approach as implemented in R using the Applied
Econometrics with R (AER) software package. In the first
stage of the analysis, fat mass and lean mass were regressed
on the genetic instruments using multivariate regression. In
the second stage of the analysis, BMD was regressed on the
predicted values from the first stage using multivariable re-
gression. Models were fitted for SK, UL, LL, SP and PE
separately. We note that the multivariable MR method
does not require every genetic instrument to be related to
every risk factor, merely that the instruments are not
related to the outcome (i.e. BMD) through paths other
than through the risk factors of interest (i.e. lean mass and
fat mass). However, multivariable MR is susceptible to
weak instrument bias. In order to minimize this possibility,
we only used seven of the most strongly related variants
from our first-stage univariate analyses (FTO, ADCY3,
MC4R, BCDIN3D, SEC16B, TMEM18 and TNNI3K)
that showed robust associations with either fat mass and/
or lean mass (i.e. Ffirst > 10, see Supplementary Table 1).
Mendelian randomization Egger regression
The other strategy we employed to evaluate the robustness
of our results was MR Egger regression.9 In this procedure,
we first fitted univariate regressions of BMD on each of the
32 BMI-related genetic instruments and recorded the value
of the slope coefficient and standard error for each variant.
We then did the same for univariate regressions of BMI/fat
mass on each of the 32 instruments. Finally, we performed
a weighted linear regression of the estimated slopes from
the first set of regressions (i.e. BMD on SNPs) on the esti-
mated slopes from the second set of regressions (i.e. BMI
fat mass on SNPs). The weights for this analysis were the
standard errors of the regression of BMD on the relevant
genetic variant. We used all 32 BMI-related SNPs in this
analysis, and examined the relationship between BMI and
fat mass with SK-, UL-, LL-, SP- and PE-BMD. The pres-
ence of directional pleiotropy was assessed by evaluating
the significance of the intercept term in the above regres-
sion and visually inspecting funnel plots. All statistical ana-
lyses were performed with R version 3.0223 using the
following software packages: AER, reshape and ggplot2.
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Results
Observational relationships of BMI, and fat mass,
on BMD
A total of 5221 children (2561 males, 2660 females) were
identified in ALSPAC who had DXA, anthropometric and
genetic data recorded at mean age 9.9 years. (Note: there
were 4223 children (2116 males and 2107 females) in the
case of SP-BMD only.). Lean mass was greater in males,
whereas fat mass was greater in female participants (Table
1). BMI, height and weight were similar in both genders.
BMD at all regions of interest was similar across the sexes.
Observationally, BMI, fat mass and lean mass were posi-
tively associated with BMD measured across all skeletal
sites. Standardized regression coefficients (with their 95%
confidence intervals) for all three ‘exposures’ were consist-
ently lower at the skull compared with the other sites after
adjustment for age and sex (Table 2).
Supplementary Table 1 presents first-stage regression
results for the BMI-associated SNPs with BMI and fat
mass in 5221 children, as well as the association with lean
mass for comparison. The majority of SNPs showed at
least nominal association (P  0.05) with BMI and fat
mass in the expected direction of association. However for
most SNPs the effect was not strong, suggesting that many
of these variants might suffer from appreciable weak in-
strument bias in our sample (i.e. Ffirst < 10). Notable ex-
ceptions included variants at the FTO, ADCY3, MC4R,
BCDIN3D, SEC16B, TMEM18 and TNNI3K loci which
were all strongly associated with BMI. First-stage regres-
sion results were similar for fat mass also, suggesting that
many of these SNPs adequately proxy adiposity. However,
the majority of SNPs also showed at least nominal associ-
ation with lean mass, including the variants in FTO and
MC4R which have been used in previous MR studies to
proxy adiposity specifically.5 Interestingly, the SNP at
ADCY3 was the only variant that showed strong associ-
ation with BMI and fat mass (Ffirst ¼ 26), but no evidence
of association with lean mass in our sample. Allelic scores
comprising all 32 variants were strongly related to BMI
(Ffirst ¼ 134) and fat mass (Ffirst ¼ 120), but also showed
considerable association with lean mass [(Ffirst ¼ 46),
Supplementary Table 1].
Instrumental variable estimates of causal effects
of BMI, and fat mass, on BMD
Supplementary Tables 4 and 5 (available as Supplementary
data at IJE online) present results for the IV regressions
using single instruments and allele scores for BMI and adi-
posity. Each IV regression coefficient estimate represents
the causal change in standard deviations of BMD per
standard deviation change in BMI/fat mass. Variants most
strongly related to BMI/adiposity produced strong positive
estimates for the causal effect of BMI and adiposity on
UL-, SP-, PE- and LL-BMD. However, their association
with SK-BMD was much more equivocal, with some vari-
ants producing positive causal estimates (e.g. MC4R,
TMEM18), whereas others displayed neutral or even nega-
tive estimates of the causal effect (e.g. SLC39A8 and
BCD1N3D). Interestingly, IV analyses involving the fat
Table 1. The descriptive statistics of dual-energy X-ray absorptiometry and anthropometric measures of participants who at-
tended the age 9 focus clinic of the Avon Longitudinal Study of Parents and Children
Male (N5 2561) Female (N5 2660)
Measure Unit Mean SD P25 Median P75 Mean SD P25 Median P75
Age Years 9.94 0.32 9.73 9.87 10.06 9.94 0.32 9.73 9.87 10.08
Height cm 139.94 6.17 135.80 139.90 144.10 139.40 6.52 134.90 139.10 143.60
Weight kg 34.47 7.20 29.40 32.80 38.00 34.98 7.59 29.60 33.40 39.20
BMI kg/m2 17.49 2.77 15.60 16.72 18.78 17.88 2.94 15.75 17.24 19.52
Fat mass kg 7.41 4.92 3.93 5.71 9.58 9.66 5.05 5.92 8.41 12.22
Lean mass kg 25.51 2.94 23.48 25.36 27.41 23.62 3.14 21.51 23.30 25.31
SK-BMD g/cm2 1.59 0.14 1.50 1.59 1.68 1.56 0.14 1.46 1.55 1.65
UL-BMD g/cm2 0.66 0.04 0.63 0.66 0.69 0.65 0.04 0.62 0.65 0.67
LL-BMD g/cm2 0.90 0.08 0.85 0.90 0.96 0.89 0.08 0.84 0.89 0.95
SP-BMDa g/cm2 0.77 0.08 0.72 0.76 0.82 0.78 0.08 0.71 0.77 0.83
PE-BMD g/cm2 0.83 0.07 0.78 0.83 0.88 0.83 0.07 0.78 0.83 0.88
Parameters presented as mean, standard deviation (SD), median, 25th (p25) and 75th (p75) centiles.
Age, age at DXA scan; fat mass, DXA-derived total body fat mass; lean mass, DXA-derived total body lean mass; BMD, DXA-derived bone mineral density.
a4223 subjects were available for analyses involving the spine (2116 males and 2107 females).
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mass-specific ADCY3 variant showed strong evidence of a
positive causal effect of fat mass on BMD at the lower-
limbs [bbIV ¼ 0.44 (0.11 - 0.77)], but not the skull,
although the confidence intervals were wide [bbIV ¼ –0.01
(–0.41 - 0.39)]. The point estimate of the causal relation-
ship between fat mass and UL-, SP- and PE-BMD using the
ADCY3 variant was intermediate between these two
estimates, but the confidence intervals overlapped zero
[UL-BMD: bbIV ¼ 0.23 (–0.13 - 0.59); SP-BMD: bbIV ¼ 0.25
(–0.18 - 0.68); PE-BMD: bbIV ¼ 0.18 (–0.19 - 0.55)].
As noted in the previous section, many of the individ-
ual variants were not strongly related to BMI or fat mass
in our sample (Ffirst < 10), and so any estimates of the
causal effect derived from these analyses are likely to be
biased towards the observational association through the
influence of weak instrument bias. We therefore com-
bined all the BMI-associated variants into a single un-
weighted allelic score. The results of the IV regressions
using the allele score as an instrument suggested that BMI
and adiposity were causally associated with BMD meas-
ured at the lower and upper limbs, spine and pelvis, but
not at the skull (see Table 2). The magnitude of the esti-
mated causal effect was larger at the lower limbs com-
pared with other regions.
Multivariable instrumental variables analysis
Multivariable IV analysis provided additional evidence of
a causal effect of fat mass on lower limb BMD, independ-
ent of the effects of lean mass [fat mass: bbIV ¼ 0.40 (0.18 -
0.62); lean mass: bbIV ¼ 0.54 (0.19 - 0.89)]. A similar
trend was observed for the upper limbs [fat mass: bbIV ¼
0.21 (0.06 - 0.47); lean mass: bbIV ¼ 0.68 (0.26 - 1.11)],
spine [fat mass: bbIV ¼ 0.31 (0.02 - 0.60); lean mass: bbIV ¼
0.44 (0.02 - 0.90)], and pelvis [fat mass: bbIV ¼ 0.24
(0.00 - 0.50); lean mass: bbIV ¼ 0.50 (0.11 - 0.90)].
However, in many cases the 95% confidence intervals for
the causal estimate for fat mass just overlapped zero. There
was no evidence for a causal effect of fat mass at the skull
[bbIV ¼ -0.08 (0.40 - 0.24), P ¼ 0.61], although there was
some evidence for a causal effect of lean mass at this site
[bbIV ¼ 0.45 (0.05 - 0.96)].
Table 2. Summary statistics describing observational (OBS) and causal relationships between BMI/fat mass and BMD measured
at several skeletal sites
BMI Fat mass
Trait Method bb CI-L CI-U P PWH bb CI-L CI-U P PWH
SK-BMD OBS 0.19 0.17 0.22 < 0.001 – 0.19 0.16 0.22 < 0.001 –
TSLS 0.02 0.20 0.15 0.78 0.01 0.03 0.22 0.16 0.78 0.02
MR-E 0.14 0.11 0.40 0.29 – 0.03 0.29 0.24 0.84 –
UL-BMD OBS 0.49 0.47 0.51 < 0.001 – 0.46 0.44 0.49 < 0.001 –
TSLS 0.46 0.31 0.61 < 0.001 0.69 0.51 0.34 0.67 < 0.001 0.60
MR-E 0.51 0.33 0.69 < 0.001 – 0.57 0.37 0.77 < 0.001 –
LL-BMD OBS 0.59 0.57 0.61 < 0.001 – 0.59 0.56 0.61 < 0.001 –
TSLS 0.55 0.41 0.68 < 0.001 0.51 0.60 0.45 0.75 < 0.001 0.87
MR-E 0.62 0.44 0.80 < 0.001 – 0.73 0.55 0.91 < 0.001 –
SP-BMD
a
OBS 0.54 0.52 0.57 < 0.001 – 0.53 0.50 0.56 < 0.001 –
TSLS 0.48 0.33 0.63 < 0.001 0.42 0.52 0.35 0.69 < 0.001 0.94
MR-E 0.61 0.40 0.83 < 0.001 – 0.49 0.29 0.70 < 0.001 –
PE-BMD OBS 0.47 0.44 0.49 < 0.001 – 0.45 0.43 0.48 < 0.001 –
TSLS 0.39 0.24 0.54 < 0.001 0.31 0.43 0.26 0.60 < 0.001 0.79
MR-E 0.49 0.34 0.64 < 0.001 – 0.47 0.31 0.62 < 0.001 –
Separate methods were used to investigate causal relationships, namely: two-stage least squares regression (TSLS) and MR-Egger regression (MR-E). Effect
sizes (bb) expressed as SD change in outcome per SD change in exposure with the upper (CI-U) and lower (CI-L) 95% confidence estimate of bb.
Observationally, lean mass was positively associated with BMD measured at the SK [bb¼ 0.25 (0.22 - 0.28)], UL [bb¼ 0.59 (0.56 - 0.61)], LL [bb¼ 0.72 (0.70 -
0.74)], SP [bb¼ 0.60 (0.58 - 0.63)] and PE [bb¼ 0.66(0.64 - 0.68)].
P, strength of evidence against the null hypothesis of no association between the outcome (BMD) and exposure variables (BMI/fat mass); PWH, the strength of
evidence against the null hypothesis of no endogeneity (i.e. no difference in effect size of the observational and the causal effect of BMI/fat mass on BMD); fat
mass, DXA-derived total body fat mass; BMD, DXA-derived bone mineral density; SK, skull; UL, upper limbs; LL, lower limbs; SP, spine; PE, pelvis.
a4223 subjects were available for analyses involving the spine (2116 males and 2107 females).
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MR Egger regression analysis
The funnel plots in Figure 2 display MAF-corrected genetic
associations between each of the individual SNPs and BMI
(panel A) / adiposity (panel B) plotted against their causal ef-
fect estimates. Visual inspection of the plots provided little
evidence for the existence of directional pleiotropy across
the different skeletal sites. This interpretation was corrobo-
rated by formal statistical tests of the intercept from the MR
Egger regression analyses (Supplementary Table 6, available
as Supplementary data at IJE online). Figure 3 illustrates the
associations between the BMI related variants and BMI
(panel A) / adiposity (panel B) with BMD at the different
skeletal sites in the form of scatter diagrams. The slope of
the line through the plot is the MR Egger regression
estimate of the causal effect using all variants as instrumen-
tal variables. Egger regression produced strong estimates of
the causal effect of BMI and fat mass on LL-BMD
[BMI: bbIV ¼ 0.62 (0.44 – 0.80); fat mass: bbIV ¼ 0.73 (0.55
– 0.91), Table 2, Figure 2 and 3], UL-BMD [BMI:
bbIV ¼ 0.51 (0.33 – 0.69); fat mass: bbIV ¼ 0.57 (0.37 –
0.77)], SP-BMD [BMI: bbIV ¼ 0.61 (0.40 – 0.83); fat mass:
bbIV ¼ 0.49 (0.29 – 0.70)] and PE-BMD [BMI: bbIV ¼ 0.49
Figure 2 Funnel plots displaying the strength of association between each of 32 SNPs (bc) with BMI (Panel A) and Fat mass (Panel B) plotted against
the causal estimate (bb IV) of each SNP on BMD measured at the skull (SK) and lower-limbs (LL). The inverse-variance weighted and MR Egger causal
effect estimates are represented by a red and blue line respectively.
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(0.34 – 0.64); fat mass: bbIV ¼ 0.47 (0.31 – 0.62)] (Table 2;
Supplementary Figures 1 and 2, available as Supplementary
data at IJE online). In contrast, whilst there was some evi-
dence for a causal relationship between BMI and SK-BMD
[bbIV ¼ 0.14 (0.11 - 0.40), although the 95% confidence
intervals overlapped zero], there was little evidence for a
causal effect of fat mass on SK-BMD [bbIV ¼ -0.03 (0.29 -
0.24), P ¼ 0.84] (Table 2, Figures 2 and 3).
Bidirectional MR analyses
Finally we investigated whether there was any evidence for
BMD having a causal effect on BMI/adiposity.
Supplementary Tables 2 and 3 present the first-stage re-
gression results for FN- and LS-BMD associated SNPs with
BMD measures at the skull, upper and lower limbs, spine
and pelvis. Many FN-BMD associated SNPs showed at
least nominal association (P  0.05) with BMD measured
Figure 3 Scatter plots displaying estimates of the association between each SNP and the relevant BMD outcome (bC) against effect estimates of each
SNP with the relevant exposure [i.e BMI (panel A) and Fat mass (panel B)]. The slope of the blue line through the plot represents the MR Egger regres-
sion estimate (bb IV) of the causal effect of the exposure on the outcome. The y-intercept of the blue regression line denotes the estimate of the degree
of directional pleiotropy in the dataset (bb 0). The inverse-variance weighted causal effect estimate is represented by the slope of the red line.
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across the different sites, consistent with previously pub-
lished work.24 However for most SNPs, the effect was not
strong, suggesting that many of these variants might suffer
from weak instrument bias in our sample if used singly (i.e.
Ffirst < 10). A similar trend was observed for LS-BMD
associated variants.
Subsequently, we combined FN- and LS-BMD associ-
ated variants into two separate unweighted allelic scores
and observed that both were robustly associated with
BMD measured at the skull (Ffirst-FN ¼ 123 and Ffirst-LS ¼
176), upper limbs (Ffirst-FN ¼ 81 and Ffirst-LS ¼ 86), lower
limbs (Ffirst-FN ¼ 79 and Ffirst-LS ¼ 51), spine (Ffirst-FN ¼ 73
and Ffirst-LS ¼ 79) and pelvis (Ffirst-FN ¼ 93 and Ffirst-LS ¼
107) (see Supplementary Tables 2 and 3). Reciprocal IV
analyses using BMD allelic scores showed no evidence of
reverse causality occurring between BMD at any of the
skeletal sites and BMI or fat mass (see Supplementary
Tables 7–16, available as Supplementary data at IJE
online).
Discussion
Our results using a variety of MR techniques involving sin-
gle and multiple genetic instruments suggest a strong
causal effect of adiposity on bone mineral density at the
lower limbs, upper limbs, spine and pelvis. A causal effect
was apparent regardless of analysis (i.e. single variant MR,
using an allelic score of 32 BMI-associated variants, using
MR Egger regression or multivariate MR) and was present
even for a variant at the ADCY3 locus that showed a rela-
tionship with fat mass but not lean mass in our sample. In
contrast, MR analyses failed to show convincing evidence
of a relationship between adiposity-associated SNPs and
skull BMD, the only exception being multivariable MR
analysis which suggested that any causal effect on BMD
was likely to be mediated through an effect of lean mass ra-
ther than adiposity. We also found no evidence for the re-
ciprocal relationship—that is, BMD having a causal effect
on BMI/adiposity.
One of the key assumptions underlying the MR ap-
proach is that the SNPs used as genetic instrumental vari-
ables are only related to the outcome of interest through
the exposure variable under study. Within the context of
the present study, this means that standard MR assumes
no pleiotropic pathways from adiposity-related SNPs to
BMD that pass through intermediates other than adiposity
(Figure 1). We have shown that this assumption is unlikely
to be fulfilled for the majority of BMI-associated variants
from the Speliotes et al. (2010) paper, since many of these
SNPs also appear to show varying degrees of association
with lean muscle mass as well as adiposity. This includes
two BMI-related variants, that were used in a previous MR
study of the same phenotypes, which exhibit non-trivial as-
sociations with lean mass in our sample.5
A notable exception appears to be a variant near
ADCY3 which was very strongly associated with fat mass/
BMI in our sample, but showed no evidence of association
with lean mass. The existence of this SNP provides an op-
portunity to test the hypothesis that adiposity causally af-
fects BMD independently of lean mass. Our results suggest
that this was indeed the case, and the fact that this effect
was present at the lower limbs and other body sites subject
to loading (i.e. the upper limbs, spine and pelvis), but not
the skull, suggests that a causal effect of fat mass on BMD
was likely to be mediated through an effect of loading ra-
ther than an endocrine mechanism. Additionally, whereas
the bones of the arms and legs differ from the skull in terms
of their type, composition and ossification processes, the
skull and pelvis share many similarities in these regards.
Given our analyses imply an effect of BMI/adiposity on
pelvic but not skull BMD, the most likely explanation for a
causal relationship between BMI/adiposity and BMD is
loading.
There are several qualifications to this interpretation.
First, although the point estimate for the causal effect of
adiposity on skull BMD using this variant was close to
zero, the confidence intervals on the causal estimate were
wide. Thus our findings would benefit from replication in
a larger sample of individuals as well as utilizing SNPs that
are specific (and strongly associated with) lean or fat mass.
Unfortunately, the common variants related to adiposity
identified in more recent genome-wide association studies
(GWAS) are even weaker than the ones used in this
study,25 and there are currently no known variants specif-
ically associated with lean mass, although there are GWAS
under way to identify such associations.
In addition we cannot rule out the possibility that the
ADCY3 variant may exhibit a small positive association
with lean mass in larger samples (i.e. the confidence inter-
vals in ALSPAC do not exclude a small effect on lean
mass), or indeed that the SNP exerts effects on BMD that
are mediated via pathways independent of adiposity.26 For
example, the ADCY3 variant has previously shown a rela-
tionship with adult height,27 although the direction of as-
sociation was in the opposite direction to its association
with BMI. In ALSPAC, the variant is strongly related to
total body fat mass but only shows nominal evidence of as-
sociation with height, as previously reported.28
Given that our results for single adiposity-related vari-
ants, the single SNPADCY3 and the allelic score of adipos-
ity-related SNPs are potentially open to confounding
influences, we employed two statistical procedures to miti-
gate concerns due to horizontal pleiotropy—MR Egger
regression9 and multivariable MR.8 Both of these
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procedures produced results very similar to our other ana-
lyses. The validity of the MR Egger approach depends on
the degree to which the INSIDE assumption is satisfied—
that is, it assumes that there is no correlation between the
strength of instrument and the strength of association with
the outcome via pathways other than through the expos-
ure. Simulations in Bowden suggest that violation of the
INSIDE assumption will result in biased estimates of the
true causal effect, depending on a number of factors
including the degree of horizontal pleiotropy present in the
data. Variants that show the strongest association with
BMI/fat mass also tend to show association with lean mass
(although this is not always true, as shown by the ADCY3
variant).
It is also unclear the extent to which weak instrument
bias has effects on MR Egger regression. Many of the vari-
ants used in our analysis are likely to suffer from this bias.
We have performed limited simulations suggesting that the
MR Egger method is susceptible to weak instrument bias,
with the exact effects depending on the number of weak in-
struments used, whether two-sample or single-sample MR
is employed and the nature of pleiotropy in the dataset
(data not shown). Specifically, the bias appears to increase
with increasing numbers of weakly associated variants and
is a key reason why we did not perform these analyses
using a far larger number of very weak instruments identi-
fied in a more recent genome-wide scan of BMI.25
Finally, bidirectional MR analyses produced no evi-
dence for the reverse relationship (i.e. BMD causing BMI/
adiposity). Genetic instruments for these analyses were se-
lected from a large genome-wide association study of
BMD in which weight was included as a covariate.21 This
has the advantage of selecting variants whose association
with BMD is not mediated through BMI/weight (i.e. the
variant’s primary association is with BMD). There is a re-
mote possibility that some of these variants are weight
variants and not at all associated with BMD, but rather
that the association is induced by a collider effect induced
by conditioning on weight.29 However, we consider this
possibility to be unlikely as there is little evidence that
these variants are associated with BMI, as noted in very
large studies of the trait.20,25
In aggregate, the results of our MR analyses suggest
that adiposity causally affects BMD. What is unclear, how-
ever, is whether the causal effect of adiposity on BMD is
mediated by lean mass (see Figure 4A), or whether SNPs
that influence adiposity influence fat mass via horizontal
pleiotropy (see Figure 4B), or perhaps a combination of
these mechanisms (Figure 4C). In favour of the first possi-
bility is the observation that many SNPs that affect fat
mass, also show evidence of association with lean mass
(under this model, given a large enough sample size we
would expect that all SNPs associated with adiposity show
association with lean mass). Such a relationship is physio-
logically plausible too. since increased fat mass may pro-
mote increased muscle mass in order to shift increased
weight, which would then causally increase BMD.
In contrast, our data provide two good reasons to sug-
gest that adiposity has, at least in part, a direct effect on
BMD that is not mediated by muscle. First, the ADCY3
variant is strongly related to adiposity in our sample, but
shows little evidence of association with lean mass. As inti-
mated, if lean mass mediated the relationship between adi-
posity and BMD we would expect that all variants related
to fat mass should show some evidence of association with
lean mass (although we acknowledge that the absence of
association with lean mass could simply reflect sampling
variation in our dataset). Also relevant are the results of
the multivariable MR analyses. Even though the multivari-
able MR model assumes a causal relationship like that
illustrated in Figure 4B, Burgess et al. (2015)8 have shown
Figure 4 Directed acyclic graphs illustrating three scenarios that poten-
tially account for the causal relationship between adiposity and bone
mineral density (BMD), in addition to the shared associations with lean
mass. Panel A depicts a scenario in which the causal influence of adi-
posity on BMD is mediated by lean mass. Panel B depicts a scenario in
which SNPs affecting adiposity also directly influence lean mass via
horizontal pleiotropy, and both fat mass and lean mass have direct
causal effects on BMD. Panel C depicts a combination of the scenarios
illustrated by panel A and B.
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that in the case of a mediated relationship like in Figure 4A
or 4C, multivariable MR analysis produces estimates of
the direct effect of the exposure variables on the outcome.
In the context of our analyses, this means that multivari-
able MR produces estimates of the direct effect of adiposity
on BMD, as opposed to the total effect of adiposity on
BMD (which would also include effects mediated by lean
mass). Thus, the fact that the multivariable MR analysis
produced significant estimates for a causal effect of fat
mass on BMD suggests that adiposity has at least some dir-
ect causal effect on BMD. We stress that our conclusions in
this regard are not definitive, and indeed our dataset is lim-
ited in terms of the information it can provide regarding
the nature of mediation. Should genetic instruments that
exclusively proxy lean mass become available in the future,
then two-step and network MR approaches may be able to
shed light on these competing hypotheses.30,31 In sum-
mary, we have used a range of different MR procedures in
this work, each with its own strengths and limitations, to
try to obtain a clearer picture of the nature of the relation-
ship between BMI/adiposity and BMD. The results of these
analyses consistently suggest that adiposity is causally
related to increased BMD at all body sites except the skull,
perhaps reflecting positive effects of loading on bone for-
mation at weighted but not unweighted sites. In contrast,
we found no evidence for the reverse relationship, i.e.
BMD causally affecting BMI or measures of adiposity. Our
results illustrate how MR can be used profitably to investi-
gate clinical questions relevant to osteoporosis and bone
health.
Supplementary Data
Supplementary data are available at IJE online.
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